| Title : In Vitro Metabolic Fate of the Synthetic Cannabinoid Receptor Agonists 2F-QMPSB and SGT-233 Including Isozyme Mapping and Carboxylesterases Activity Testing - Richter_2022_J.Anal.Toxicol__ |
| Author(s) : Richter MJ , Wagmann L , Brandt SD , Meyer MR |
| Ref : J Anal Toxicol , : , 2022 |
| Abstract : |
| PubMedSearch : Richter_2022_J.Anal.Toxicol__ |
| PubMedID: 36083120 |
| Title : In vitro metabolic fate of the synthetic cannabinoid receptor agonists QMMSB (quinolin-8-yl 4-methyl-3-(morpholine-4-sulfonyl)benzoate) and QMiPSB (quinolin-8-yl 4-methyl-3-[(propan-2-yl)sulfamoyl]benzoate) including isozyme mapping and carboxylesterases activity testing - Richter_2022_Drug.Test.Anal__ |
| Author(s) : Richter MJ , Wagmann L , Kavanagh PV , Brandt SD , Meyer MR |
| Ref : Drug Test Anal , : , 2022 |
| Abstract : |
| PubMedSearch : Richter_2022_Drug.Test.Anal__ |
| PubMedID: 36239626 |
| Title : In Vitro Metabolic Fate of the Synthetic Cannabinoid Receptor Agonists QMPSB and QMPCB (SGT-11) Including Isozyme Mapping and Esterase Activity - Richter_2021_Metabolites_11_ |
| Author(s) : Richter MJ , Wagmann L , Gampfer TM , Brandt SD , Meyer MR |
| Ref : Metabolites , 11 : , 2021 |
| Abstract : |
| PubMedSearch : Richter_2021_Metabolites_11_ |
| PubMedID: 34436449 |
| Title : Synthetic cannabinoid receptor agonists: Analytical profiles and development of QMPSB, QMMSB, QMPCB, 2F-QMPSB, QMiPSB, and SGT-233 - Brandt_2021_Drug.Test.Anal_13_175 |
| Author(s) : Brandt SD , Kavanagh PV , Westphal F , Dreiseitel W , Dowling G , Bowden MJ , Williamson JPB |
| Ref : Drug Test Anal , 13 :175 , 2021 |
| Abstract : |
| PubMedSearch : Brandt_2021_Drug.Test.Anal_13_175 |
| PubMedID: 32880103 |